Danaher Corp (DHR) Stock Price, Quote & News

Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell cultu...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 202 828 0850

Fax: 202 828 0860

Website: www.danaher.com

Address:

2200 Pennsylvania Avenue N.W., Suite 800W, Washington, United States

PenkeInvesting Jul. 25 at 5:40 AM

Fundamental analysis of $DHR (DANAHER CORP /DE/) based on financial data and reported results. #DHR #DANAHER

0 · Reply

11thestate Jul. 24 at 2:27 PM

Imagine buying $DHR at its peak, only to watch it crash like this and then finding out there’s a way to get some money back. To all $DHR investors out there, we’ve got some important news: a $172.5 million investor settlement is now open for claims from shareholders who purchased shares between 2020 and 2023. The deadline is in two months, you can check if you’re eligible and claim your share: https://11th.com/cases/danaher-investor-settlement

0 · Reply

Broview Jul. 24 at 7:52 AM

$DHR building?

0 · Reply

jake0T Jul. 24 at 5:55 AM

$CNSP $CDT $EDBL $DHR $TMO Bull Flag Price action. CNS-Pharmaceuticals CNSP is rebounding. Now get on the CNS Pharmaceuticals CNSP moon rocket 9700% on Monday open. FAST TRACK DESIGNATION + ORPHAN DRUG DESIGNATION + INTELLECTUAL PROPERTY COMMERCIALIZATION RIGHTS in E.U. & U.S.

0 · Reply

InItToWinIt100 Jul. 24 at 4:44 AM

$DHR Fingers crossed for a move above $195 in the morning!

0 · Reply

Popo_Jijo Jul. 23 at 11:07 PM

$DHR in other words, if rainer knew how to lead an organization and orchestrate an earnings call like his counterpart at thermo fisher so much of the past two days, -10%+ worth and likely more to come, would not have been necessary. good grief.

0 · Reply

InItToWinIt100 Jul. 23 at 7:41 PM

$DHR $195 target https://www.trade-ideas.com/share.php?code=ZO6iDT4RjzOH4JrSZ76YSVOVOt2X5PAy

0 · Reply

Aleexandder Jul. 23 at 5:31 PM

$DHR The biotechnology segment has been a major growth driver, with bioprocessing equipment orders up more than 30% earlier this year, supported by pharmaceutical manufacturing demand!!

0 · Reply

m322m Jul. 23 at 2:58 PM

$DHR I sell yesterday My problem I can't wait 😶‍🌫️

0 · Reply

cubie Jul. 23 at 12:42 PM

$TMO $DHR $LMT $RTX $NOC cubie teaches price action. they knew

1 · Reply

Danaher’s recent volatility presents buying opportunity, says Argus

2026-07-22T13:00:19.000Z - 5 days ago

Danaher price target lowered to $240 from $250 at Deutsche Bank

2026-07-22T12:45:26.000Z - 5 days ago

Danaher price target lowered to $230 from $270 at BofA

2026-07-22T12:35:36.000Z - 5 days ago

Danaher price target lowered to $236 from $240 at TD Cowen

2026-07-22T11:21:07.000Z - 5 days ago

Danaher price target raised to $215 from $200 at RBC Capital

2026-07-22T11:10:55.000Z - 5 days ago

Danaher price target lowered to $220 from $260 at Stifel

2026-07-22T10:35:42.000Z - 5 days ago

Danaher price target lowered to $200 from $235 at Guggenheim

2026-07-22T10:31:09.000Z - 5 days ago

Danaher price target lowered to $195 from $212 at Wells Fargo

Jul 22, 2026, 5:06 AM EDT - 5 days ago

Don't Quit on Danaher Stock After Horrific Earnings Reaction

2026-07-21T16:23:31.000Z - 5 days ago

Danaher Stock (DHR) Is Down 13% and Suffering Its Worst Decline in 30 Years. Here’s Why

2026-07-21T16:05:28.000Z - 5 days ago

Danaher falls -14.3%

2026-07-21T14:15:23.000Z - 6 days ago

Bio-Rad slips as Sartorius weighed on by Danaher bioprocessing unit miss

BIO

2026-07-21T14:06:03.000Z - 6 days ago

Danaher falls -12.4%

Jul 21, 2026, 8:39 AM EDT - 6 days ago

Danaher's revenue outlook cut, biotech miss overshadow profit forecast raise

Jul 21, 2026, 8:00 AM EDT - 6 days ago

Danaher Earnings Call Transcript: Q2 2026

Jul 21, 2026, 8:00 AM EDT - 6 days ago

Danaher Quarterly report: Q2 2026

Jul 21, 2026, 8:00 AM EDT - 6 days ago

Danaher Earnings release: Q2 2026

Jul 21, 2026, 8:00 AM EDT - 6 days ago

Danaher Slides: Q2 2026

2026-07-21T10:07:16.000Z - 6 days ago

Danaher reports Q2 adjusted EPS $1.94, consensus $1.84

2026-07-21T10:07:10.000Z - 6 days ago

Danaher sees Q3 non-GAAP core revenue up 2%-3% y/y

2026-07-21T10:07:04.000Z - 6 days ago

Danaher sees FY26 non-GAAP core revenue up 3%-4% y/y

2026-07-21T10:06:51.000Z - 6 days ago

Danaher raises FY26 adjusted EPS view to $8.45-$8.60 from $8.35-$8.55

Jul 21, 2026, 6:00 AM EDT - 6 days ago

Danaher Reports Second Quarter 2026 Results

Jul 3, 2026, 12:26 PM EDT - 23 days ago

Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Jun 29, 2026, 8:30 AM EDT - 4 weeks ago

Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa

Jun 25, 2026, 1:00 PM EDT - 4 weeks ago

The Big 3: JPM, DHR, MRK

JPM MRK

Jun 22, 2026, 4:15 PM EDT - 4 weeks ago

Danaher Schedules Second Quarter 2026 Earnings Conference Call

Jun 17, 2026, 12:30 PM EDT - 5 weeks ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX

Jun 10, 2026, 8:55 AM EDT - 6 weeks ago

Danaher Completes Acquisition of Masimo Corporation

Jun 8, 2026, 6:09 PM EDT - 6 weeks ago

Sirius XM Holdings Set to Join S&P MidCap 400

SPGI

Jun 1, 2026, 2:00 PM EDT - 7 weeks ago

SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations

Jun 1, 2026, 2:00 PM EDT - 7 weeks ago

SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools

May 15, 2026, 1:00 AM EDT - 2 months ago

Even a High-Priced Market Has Bargains. 10 Undervalued Blue-Chip Stocks.

ABT ACN HD MCD MDT MKC RSG

May 13, 2026, 2:20 PM EDT - 2 months ago

Danaher Transcript: Bank of America Global Healthcare Conference 2026

May 6, 2026, 4:15 PM EDT - 2 months ago

Danaher to Present at Bank of America Securities Healthcare Conference

May 5, 2026, 4:30 PM EDT - 2 months ago

Danaher Announces Quarterly Dividend

May 5, 2026, 3:00 PM EDT - 2 months ago

Danaher Transcript: AGM 2026

May 4, 2026, 9:00 AM EDT - 3 months ago

Masimo Shareholders Approve Acquisition by Danaher

MASI

Apr 23, 2026, 1:39 PM EDT - 3 months ago

Danaher reaches $172.5 million settlement with shareholders over post-pandemic outlook

Apr 22, 2026, 7:15 PM EDT - 3 months ago

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

Apr 21, 2026, 8:00 AM EDT - 3 months ago

Danaher Earnings Call Transcript: Q1 2026

Apr 21, 2026, 8:00 AM EDT - 3 months ago

Danaher Earnings release: Q1 2026

Apr 21, 2026, 8:00 AM EDT - 3 months ago

Danaher Quarterly report: Q1 2026

Apr 21, 2026, 8:00 AM EDT - 3 months ago

Danaher Slides: Q1 2026

Apr 21, 2026, 7:33 AM EDT - 3 months ago

Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains

Apr 21, 2026, 7:28 AM EDT - 3 months ago

Danaher beats first-quarter profit estimates on strong bioprocessing demand

Apr 21, 2026, 6:00 AM EDT - 3 months ago

Danaher Reports First Quarter 2026 Results

Apr 13, 2026, 3:01 AM EDT - 3 months ago

Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes

Mar 25, 2026, 8:00 AM EDT - 4 months ago

Danaher Proxy statement: Proxy filing

Mar 25, 2026, 8:00 AM EDT - 4 months ago

Danaher Proxy statement: Proxy filing

Mar 20, 2026, 4:15 PM EDT - 4 months ago

Danaher Schedules First Quarter 2026 Earnings Conference Call

Mar 3, 2026, 1:50 PM EST - 5 months ago

Danaher Transcript: TD Cowen 46th Annual Health Care Conference

Feb 26, 2026, 7:00 AM EST - 5 months ago

Danaher Slides: Corporate presentation

Feb 24, 2026, 4:05 PM EST - 5 months ago

Danaher to Present at TD Cowen Health Care Conference

Feb 17, 2026, 8:04 AM EST - 5 months ago

Danaher to buy Masimo for $9.9 billion

MASI

Feb 17, 2026, 8:02 AM EST - 5 months ago

Masimo to be Acquired by Danaher for $180.00 Per Share

MASI

Feb 17, 2026, 8:00 AM EST - 5 months ago

Danaher To Acquire Masimo Corporation

MASI

Feb 17, 2026, 6:09 AM EST - 5 months ago

Danaher Strikes $10 Billion Deal for Masimo

MASI

Feb 16, 2026, 11:11 PM EST - 5 months ago

Danaher closes in on nearly $10 billion deal for Masimo, FT reports

MASI

Feb 12, 2026, 12:30 PM EST - 5 months ago

Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights

Jan 28, 2026, 8:00 AM EST - 6 months ago

Danaher Earnings Call Transcript: Q4 2025

Jan 28, 2026, 8:00 AM EST - 6 months ago

Danaher Annual report: Q4 2025

Jan 28, 2026, 8:00 AM EST - 6 months ago

Danaher Earnings release: Q4 2025

Jan 28, 2026, 8:00 AM EST - 6 months ago

Danaher Slides: Q4 2025

Jan 28, 2026, 7:08 AM EST - 6 months ago

Danaher forecasts 2026 profit in line with estimates on pharma spending recovery

Jan 28, 2026, 6:00 AM EST - 6 months ago

Danaher Reports Fourth Quarter and Full Year 2025 Results

Jan 13, 2026, 2:15 PM EST - 6 months ago

Danaher Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 2:15 PM EST - 6 months ago

Danaher Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 9:00 AM EST - 7 months ago

Danaher CEO to Comment on Financial Performance

Jan 8, 2026, 1:05 PM EST - 7 months ago

The Big 3: BA, DHR, DG

BA DG

Jan 8, 2026, 8:00 AM EST - 7 months ago

Danaher Is Ready to Put Its Post-Covid Malaise Behind It

Jan 5, 2026, 4:15 PM EST - 7 months ago

Danaher to Present at J.P. Morgan Healthcare Conference

Dec 24, 2025, 11:48 AM EST - 7 months ago

HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dec 17, 2025, 7:30 AM EST - 7 months ago

Danaher Schedules Fourth Quarter 2025 Earnings Conference Call

Dec 4, 2025, 12:15 PM EST - 8 months ago

6 Dividend Stocks Ready To Benefit From 2026's Rate-Shift Economy

DX HSY NLY BMEZ UTG

Nov 18, 2025, 4:29 PM EST - 8 months ago

3 More Good Stocks to Invest In After Earnings

FTNT LPLA

Nov 18, 2025, 6:00 AM EST - 8 months ago

Danaher Transcript: Jefferies London Healthcare Conference 2025

Nov 13, 2025, 12:50 PM EST - 9 months ago

The Big 3: TMO, DHR, VLO

TMO VLO

Nov 11, 2025, 4:15 PM EST - 9 months ago

Danaher to Present at Jefferies Global Healthcare Conference

Oct 21, 2025, 10:55 AM EDT - 9 months ago

Is Danaher's Q3 beat enough to reignite long-term growth for DHR investors?

Oct 21, 2025, 8:00 AM EDT - 9 months ago

Danaher Earnings Call Transcript: Q3 2025

Oct 21, 2025, 8:00 AM EDT - 9 months ago

Danaher Quarterly report: Q3 2025

Oct 21, 2025, 8:00 AM EDT - 9 months ago

Danaher Earnings release: Q3 2025

Oct 21, 2025, 8:00 AM EDT - 9 months ago

Danaher Slides: Q3 2025

Oct 21, 2025, 7:01 AM EDT - 9 months ago

Danaher beats quarterly estimates on strength in diagnostic tools and tech

Oct 21, 2025, 6:23 AM EDT - 9 months ago

Danaher Sales and Profit Rise on Bioprocessing Momentum

Oct 21, 2025, 6:00 AM EDT - 9 months ago

Danaher Reports Third Quarter 2025 Results

PenkeInvesting Jul. 25 at 5:40 AM

Fundamental analysis of $DHR (DANAHER CORP /DE/) based on financial data and reported results. #DHR #DANAHER

0 · Reply

11thestate Jul. 24 at 2:27 PM

0 · Reply

Broview Jul. 24 at 7:52 AM

$DHR building?

0 · Reply

jake0T Jul. 24 at 5:55 AM

0 · Reply

InItToWinIt100 Jul. 24 at 4:44 AM

$DHR Fingers crossed for a move above $195 in the morning!

0 · Reply

Popo_Jijo Jul. 23 at 11:07 PM

0 · Reply

InItToWinIt100 Jul. 23 at 7:41 PM

$DHR $195 target https://www.trade-ideas.com/share.php?code=ZO6iDT4RjzOH4JrSZ76YSVOVOt2X5PAy

0 · Reply

Aleexandder Jul. 23 at 5:31 PM

$DHR The biotechnology segment has been a major growth driver, with bioprocessing equipment orders up more than 30% earlier this year, supported by pharmaceutical manufacturing demand!!

0 · Reply

m322m Jul. 23 at 2:58 PM

$DHR I sell yesterday My problem I can't wait 😶‍🌫️

0 · Reply

cubie Jul. 23 at 12:42 PM

$TMO $DHR $LMT $RTX $NOC cubie teaches price action. they knew

1 · Reply

cubie Jul. 23 at 12:01 PM

$TMO $DHR see @judgeyoung2 atm is contrarian, dhr was just the outlier😅

1 · Reply

OnlyFibs Jul. 23 at 2:03 AM

Danaher Corporation $DHR anchors global life sciences and diagnostics innovation while maintaining strong operating fundamentals. Price action is holding a key support pivot on the 8 hour chart near the 178.72 dollar zone, backed by notable institutional option sweeps including the 12/18/2026 195.00 dollar calls printing over 170,000 dollars in premium and 08/07/2026 185.00 dollar call sweeps hitting the Ask. 🐂🎯 Bull Key Levels: A firm break and hold above the 185.00 dollar resistance ceiling is required to confirm momentum continuation toward upper supply zones. 🐂🔥 Bear Key Levels: Bulls must defend the 170.00 dollar support floor to keep this recovery structure intact. 🐻⚠️ Take Profit Targets: 192.00 / 202.00 dollars. 💰💸 #hovdid $DHR #lifesciences #stocks #trading

0 · Reply

SaiyanPride1 Jul. 22 at 8:26 PM

$DHR

0 · Reply

ok2buy Jul. 22 at 7:09 PM

$DHR LMAO. This did go green today! Congrats again to those who bought $173's.

0 · Reply

ok2buy Jul. 22 at 3:31 PM

$DHR More fuel still in the tank. Wouldn't that be a statement if this actually closes green today./

0 · Reply

ok2buy Jul. 22 at 3:26 PM

$DHR And as predicted $176 +. I knew it! So greasy over the past few days. Did not deserve to be punished like it was./

0 · Reply

ok2buy Jul. 22 at 3:20 PM

$DHR Wants to go now.

0 · Reply

ok2buy Jul. 22 at 3:13 PM

$DHR I see a few analyst price targets now at $200/share after they dropped their targets. I also see some analysts with targets still above $300. Still very widely followed by institutions. I think we are at or very close to bottom./

0 · Reply

ok2buy Jul. 22 at 3:01 PM

$DHR Congrats to those who bought today $173's. You will be rewarded./

0 · Reply

ok2buy Jul. 22 at 3:00 PM

$DHR Back through $175, push to $176+. Still in the cards for today IMO./ok2

0 · Reply

SaiyanPride1 Jul. 22 at 2:39 PM

$DHR $DHR one important thing about the SSR rule where shorts can’t sell at current prices to drive down price after a -10% (+) day, is that they can still sell above the ask, essentially walling the price and creating panic sell scenarios that can artificially drive the price down. Today’s move is senseless, and I think this is exactly what happened. The short interest on this is extremely low. So any pressure will be short lived imho.

0 · Reply

ok2buy Jul. 22 at 2:24 PM

$DHR Thanks to the seller./

0 · Reply

Market Cap	134.62B
Revenue (ttm)	24.57B
Net Income (ttm)	3.61B
EPS (ttm)	N/A
PE Ratio	23.71
Forward PE	22.57
Profit Margin	14.71%
Debt to Equity Ratio	0.33

Volume	6,849,400
Avg Vol	5,095,024
Day's Range	N/A - N/A
Shares Out	702.99M
Stochastic %K	63%
Beta	0.79
Analysts	Strong Sell
Price Target	$225.00